DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

Wall Street reassessment: analyst coverage of Doximity moved from applauding "record engagement" to placing DOCS in the "penalty box," as a securities class action alleges the Company overstated its Newsfeed's contribution to revenue growth and misstated its competitive position. SueWallSt alerts investors in Doximity, Inc. that a securities class action has been filed on behalf of shareholders who purchased or acquired common stock between August 8, 2024 and May 13, 2026. Find out if you may be eligible to recover losses. DOCS fell $5.38 per share, or 23%, from a closing price of $23.39 on May 13, 2026 to $18.01 on May 14, 2026. That followed a $5.59 per share decline (17%) on February 6, 2026 and an $8.29 per share decline (13%) on November 7, 2025. LEAD PLAINTIFF DEADLINE: November 16, 2026. Through fiscal 2025 and into fiscal 2026, sell-side coverage tracked management's repeated message of "record engagement" and described the Newsfeed as the Company's most used and most monetized product. The action alleges those representations overstated the Newsfeed's impact on revenue growth while Doximity was allegedly losing share to competitors with more favorable pricing and engagement models. After the February 5, 2026 guidance reduction, analysts noted that "uncertainty is lingering," and an Evercore analyst observed that older companies such as Doximity "are losing share while programmatic, social, and other new formats are gaining share." By May 13, 2026, coverage indicated a sharp reassessment of the Company's growth trajectory. Analyst Coverage Timeline November 6, 2025: caution expressed on the ad spending outlook, with an implied slowdown in second-half fiscal 2026 sales growth; shares declined 13%. February 5, 2026: fiscal 2026 revenue guidance lowered; analysts noted decelerating sales growth and contracting net income. February 5, 2026: Evercore coverage attributed share loss to newer programmatic and social advertising formats. May 13, 2026: Freeman Capital Markets called the news "a tough pill to swallow" as shares fell to "an all-time low." May 13, 2026: Jefferies and Leerink Partners each placed DOCS in the "penalty box," with Leerink citing the "shock value" of the dynamics behind the guidance, including market softness and timing of commitments. May 13, 2026: RBC Capital Markets noted that stalled net revenue retention suggested an "increasingly competitive market." Ratings and price targets are built on company disclosures. The lawsuit contends that shareholders paid artificially inflated prices while the Company's reported engagement metrics allegedly obscured deteriorating competitive position. "When analyst expectations are built on incomplete or misleading company disclosures, the resulting corrections can cause significant investor harm. Here, analysts moved within months from crediting record engagement to questioning whether Doximity was losing share to newer advertising formats." Submit your information to learn more or call (888) SueWallSt.